Advances on Nanomedicines for Diagnosis and Theranostics of Hepatic Fibrosis-Reference-Cited by-同舟云学术

Advances on Nanomedicines for Diagnosis and Theranostics of Hepatic Fibrosis

Published:2021-05-03 Issue:7 Volume:1 Page:2000091
ISSN:2699-9307
Container-title:Advanced NanoBiomed Research
language:en
Short-container-title:Adv NanoBio Res

Author:

Dai Xinghang¹²,Zeng Yujun¹,Zhang Hu¹³,Gu Zhongwei⁴,Gong Qiyong¹⁴,Luo Kui¹⁴^ORCID

Affiliation:

1. Huaxi MR Research Center (HMRRC) Department of Radiology Functional and molecular imaging Key Laboratory of Sichuan Province West China Hospital Sichuan University Chengdu 610041 China

2. West China School of Medicine Sichuan University Chengdu 610041 China

3. Amgen Bioprocessing Centre Keck Graduate Institute CA 91711 USA

4. Research Unit of Psychoradiology Chinese Academy of Medical Sciences Chengdu 610041 China

Funder

National Natural Science Foundation of China

Department of Science and Technology of Sichuan Province

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anbr.202000091

Reference160 articles.

1. Reversibility of Liver Fibrosis and Inactivation of Fibrogenic Myofibroblasts

2. Hepatic fibrosis: Concept to treatment

3. Cystic Fibrosis-related cirrhosis

4. Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI

5. Predictors for the progression of hepatic cirrhosis to hepatocellular carcinoma under long-term antiviral therapy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyaluronic acid modified extracellular vesicles targeting hepatic stellate cells to attenuate hepatic fibrosis;European Journal of Pharmaceutical Sciences;2024-07

2. Nanomedicines for high‑intensity focused ultrasound cancer treatment and theranostics (Review);Experimental and Therapeutic Medicine;2023-03-03